Systemic lupus erythematosus following rituximab treatment for non-Hodgkin lymphoma

J Dtsch Dermatol Ges. 2016 Mar;14(3):298-301. doi: 10.1111/ddg.12751. Epub 2016 Jan 20.

Authors

Efthymia Soura¹, Georgia Avgerinou¹, Marina Papoutsaki¹, Panagiotis Stavropoulos¹, Christina Antoniou¹

Affiliation

¹ 1st University Department of Dermatology/Venereology, Andreas Syggros Hospital, University of Athens, Athens, Greece.

PMID: 26788717
DOI: 10.1111/ddg.12751

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antineoplastic Agents / adverse effects
Antineoplastic Agents / therapeutic use
Diagnosis, Differential
Drug Eruptions / diagnosis*
Drug Eruptions / etiology
Drug Eruptions / therapy
Female
Humans
Lupus Erythematosus, Systemic / chemically induced*
Lupus Erythematosus, Systemic / diagnosis*
Lupus Erythematosus, Systemic / therapy
Lymphoma, Non-Hodgkin / complications
Lymphoma, Non-Hodgkin / drug therapy*
Middle Aged
Rituximab / adverse effects*
Rituximab / therapeutic use*
Treatment Outcome

Substances

Antineoplastic Agents
Rituximab